Abstract
Loss-of-function mutations in the LKB1 (STK11) serine–threonine kinase gene cause Peutz–Jeghers syndrome, which is associated with inherited susceptibility to colorectal and other cancers. No downstream targets of LKB1 kinase activity have been identified. Here we show that LKB1 can direct the phosphorylation of the serine–threonine kinase PAR1A. The amino-acid residues phosphorylated as a result of LKB1 activity have been identified and phosphorylation at these residues is required for PAR1A kinase activity. PAR1A has previously been implicated as a positive regulator of the Wnt-βcatenin signalling pathway. We show here that LKB1 can modify transcription driven by the Wnt-regulated TCF response element, implicating LKB1 in a pathway known to play a key role in human colorectal tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- EST:
-
expressed sequence tag
- MAP:
-
microtubule-associated protein
- MARK:
-
MAP/microtubule affinity-regulating kinase
- PJS:
-
Peutz–Jeghers syndrome
- STK:
-
serine/threonine kinase
References
Back W, Loff S, Jenne D and Bleyl U . (1999). J. Clin. Pathol., 52, 345–349.
Bosman FT . (1999). J. Pathol., 188, 1–2.
Drewes G, Ebneth A, Preuss U, Mandelkow EM and Mandelkow E . (1997). Cell, 89, 297–308.
Esteller M, Avizienyte E, Corn PG, Lothe RA, Baylin SB, Aaltonen LA and Herman JG . (2000). Oncogene, 19, 164–168.
Guo S and Kemphues KJ . (1995). Cell, 81, 611–620.
Jan YN and Jan LY . (2000). Cell, 100, 599–602.
Johnson LN, Noble ME and Owen DJ . (1996). Cell, 85, 149–158.
Karuman P, Gozani O, Odze R D, Zhou X C, Zhu H, Shaw R, Brien T P, Bozzuto C D, Ooi D, Cantley L C and Yuan J . (2001). Mol. Cell, 7, 1307–1319.
Korinek V, Barker N, Morin PJ, Van Wichen D, De Weger R, Kinzler KW, Vogelstein B and Clevers H . (1997). Science, 275, 1784–1787.
Marignani P A, Kanai F and Carpenter C L . (2001). J. Biol. Chem., 276, 32415–32418.
Martin S G and St Johnston D . (2003). Nature, 421, 379–384.
Mehenni H, Gehrig C, Nezu J, Oku A, Shimane M, Rossier C, Guex N, Blouin JL, Scott HS and Antonarakis SE . (1998). Am. J. Hum. Genet, 63, 1641–1650.
Miyoshi H, Nakau M, Ishikawa T, Seldin MF, Oshima M and Taketo MM . (2002). Cancer Res., 62, 2261–2266.
Nakau H, Miyoshi H, Seldin M, Imamura M, Oshima M and Taketo M . (2002). Cancer Res., 62, 4549–4553.
Parsa I . (1988). Cancer Res., 48, 2265–2272.
Peng CY, Graves PR, Ogg S, Thoma RS, Byrnes III MJ, Wu Z, Stephenson MT and Piwnica-Worms H . (1998). Cell Growth Differ., 9, 197–208.
Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM, Westra WH, Sherman JG and Sidransky D . (2002). Cancer Res., 62, 3659–3662.
Smalley MJ, Sara E, Paterson H, Naylor S, Cook D, Jayatilake H, Fryer LG, Hutchinson L, Fry MJ and Dale TC . (1999). EMBO J., 18, 2823–2835.
Smith DP, Rayter SI, Niederlander C, Spicer J, Jones CM and Ashworth A . (2001). Hum. Mol. Genet., 10, 2869–2877.
Smith DP, Spicer J, Smith A, Swift S and Ashworth A . (1999). Hum. Mol. Genet., 8, 1479–1485.
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ and Williams LT . (2001). Nat. Cell Biol., 3, 628–636.
Tiainen M, Ylikorkala A and Makela TP . (1999). Proc. Natl. Acad. Sci. USA, 96, 9248–9251.
Tomlinson IP and Houlston RS . (1997). J. Med. Genet., 34, 1007–1011.
Watts JL, Morton DG, Bestman J and Kemphues KJ . (2000). Development, 127, 1467–1475.
Yoo LI, Chung DC and Yuan J . (2002). Nat. Rev. Cancer, 2, 529–535.
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR and Sen S . (1998). Nat. Genet., 20, 189–193.
Acknowledgements
JS was the recipient of an Institute of Cancer Research clinical research fellowship. This work was supported by Cancer Research UK and Breakthrough Breast Cancer. We thank Trevor Dale, Institute of Cancer Research, for providing reagents for the reporter assay.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spicer, J., Rayter, S., Young, N. et al. Regulation of the Wnt signalling component PAR1A by the Peutz–Jeghers syndrome kinase LKB1. Oncogene 22, 4752–4756 (2003). https://doi.org/10.1038/sj.onc.1206669
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206669
Keywords
This article is cited by
-
Loss of liver kinase B1 causes planar polarity defects in cochlear hair cells in mice
Frontiers of Medicine (2016)
-
Inactivation of the LKB1-AMPK signaling pathway does not contribute to salivary gland tumor development - a short report
Cellular Oncology (2016)
-
Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro
Molecular and Cellular Biochemistry (2015)
-
The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma
Tumor Biology (2014)
-
The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling
Oncogene (2011)